Date:
February
25,
2004
Subject:
Cost,
Environmental,
and
Energy
Impacts
Associated
with
Facilities
Potentially
Eligible
for
the
Delisted
Low­
Risk
Subcategory
of
Plywood
and
Composite
Wood
Products
Facilities
EPA
Contract
No.
68­
D­
1­
079;
EPA
Work
Assignment
No.
2­
12
RTI
Project
No.
08550.002.012
From:
Katie
Hanks
To:
Mary
Tom
Kissell,
ESD/
WCPG
(
C439­
03)
U.
S.
Environmental
Protection
Agency
Research
Triangle
Park,
NC
27711
The
final
plywood
and
composite
wood
products
(
PCWP)
national
emission
standards
for
hazardous
air
pollutants
(
NESHAP)
contains
criteria
defining
a
subcategory
of
low­
risk
PCWP
facilities.
Facilities
that
can
demonstrate
that
they
are
part
of
this
delisted
low­
risk
subcategory
are
not
required
to
comply
with
the
final
rule.
Therefore,
the
impacts
of
the
final
rule
will
be
reduced.
The
change
in
environmental,
energy,
and
economic
impacts
associated
with
inclusion
of
the
low­
risk
subcategory
option
in
the
final
PCWP
rule
are
summarized
in
this
memorandum.

To
estimate
the
potential
baseline
risks
posed
by
the
PCWP
source
category
and
the
potential
impact
of
a
delisted
low­
risk
subcategory,
EPA
performed
a
rough
risk
assessment
for
181
of
the
223
major
source
facilities
in
the
PCWP
source
category.
All
hazardous
air
pollutants
(
HAP)
emitted
from
PCWP
facilities
were
included
in
the
assessment.
Of
the
223
major
sources,
facilities
where
available
location
data
were
ambiguous
or
where
all
of
their
site­
specific
information
was
requested
to
be
treated
as
confidential
were
excluded
from
the
analysis,
leaving
a
total
of
181
facilities
in
the
assessment.
For
the
risk
assessment,
EPA
used
baseline
emission
estimates
(
developed
using
average
emission
factors
and,
if
available,
site­
specific
process
throughput
data)
and
model
PCWP
emissions
release
characteristics
as
inputs
into
our
Human
Exposure
Model
(
HEM)
to
generate
cancer
and
non­
cancer
risk
estimates
for
the
181
PCWP
facilities.
The
risk
assessment
methodology
is
explained
in
detail
in
a
separate
memorandum.
1
Based
on
the
results
of
this
assessment,
147
facilities
could
potentially
be
eligible
for
inclusion
in
the
delisted
low­
risk
subcategory
based
on
a
cancer
risk
level
of
one
in
a
million
and
target
organ
specific
hazard
index
(
TOSHI)
limits
of
1
for
respiratory
and
central
nervous
system
2
(
CNS)
effects,
provided
these
assessments
are
confirmed
by
source­
specific
demonstrations.
Attachment
1
summarizes
the
HEM
output
for
these
147
facilities.
In
addition,
as
discussed
in
the
preamble
to
the
final
PCWP
rule,
EPA
determined
that
eight
facilities
are
eligible
for
inclusion
in
the
delisted
low­
risk
subcategory
based
on
a
cancer
risk
of
0.1
in
1
million,
TOSHI
of
less
than
0.1,
and
other
criteria.

The
number
of
impacted
PCWP
facilities
is
shown
in
Table
1.
Of
the
223
PCWP
major
sources,
166
of
these
facilities
would
have
been
expected
to
install
air
pollution
control
devices
(
APCD)
in
the
absence
of
any
delisted
low­
risk
subcategory.
The
remaining
facilities
are
not
impacted
by
control
costs
because
they
either
already
have
installed
add­
on
controls,
do
not
have
any
process
units
subject
to
the
compliance
options,
or
are
expected
to
comply
with
work
practice
requirements
only.
Four
of
the
eight
facilities
eligible
for
inclusion
in
the
delisted
low­
risk
subcategory
would
have
been
impacted
by
maximum
achievable
control
technology
(
MACT)
control
requirements.
Thus,
considering
the
facilities
eligible
for
inclusion
in
the
delisted
low­
risk
subcategory,
162
facilities
(
166
­
4
=
162)
would
be
expected
to
install
APCD.
Of
the
147
facilities
that
may
later
be
eligible
for
inclusion
in
the
low­
risk
subcategory,
108
would
have
been
impacted
by
MACT
control
requirements
in
the
absence
of
the
delisted
subcategory.
Thus,
considering
the
facilities
that
may
later
demonstrate
eligibility
for
the
delisted
low­
risk
subcategory,
58
facilities
(
166
­
108
=
58)
would
be
expected
to
install
APCD.

Tables
2
through
5
summarize
the
regulatory
impacts
estimated
for
three
scenarios:
(
1)
no
low­
risk
subcategory,
(
2)
the
low­
risk
subcategory
containing
the
group
of
eight
PCWP
facilities
that
are
already
eligible
for
the
low­
risk
subcategory,
and
(
3)
a
low­
risk
subcategory
containing
the
147
PCWP
facilities
that
may
later
become
low­
risk
provided
they
submit
a
site­
specific
demonstration.
The
methodology
used
to
develop
the
regulatory
impacts,
and
the
regulatory
impacts
associated
with
the
final
PCWP
rule
in
the
absence
of
any
low­
risk
subcategory
are
presented
in
a
separate
memorandum.
2
Each
table
presents
the
regulatory
impacts
associated
with
each
scenario
alone,
and
then
overall
considering
removal
of
the
low­
risk
facilities
from
the
PCWP
source
category.
Table
2
presents
nationwide
cost
impacts.
Table
3
presents
nationwide
air
impacts
at
PCWP
facilities.
Table
4
presents
secondary
air
impacts
associated
with
coal­
fired
utility
plants.
Table
5
presents
the
wastewater,
solid
waste,
and
energy
impacts.

References:

1.
Memorandum
from
S.
Jenkins,
M.
Pimentel,
and
D.
Pagano
EPA/
REAG
to
D.
Guinnup
EPA/
REAG.
February
2004.
Risk
assessment
for
the
final
maximum
achievable
control
technology
(
MACT)
rule
for
the
plywood
and
composite
wood
products
(
PCWP)
source
category.

2.
Memorandum
from
K.
Parrish,
RTI,
to
M.
Kissell,
EPA/
WCPG.
January
21,
2004.
Environmental
and
Energy
Impacts
for
the
Final
Plywood
and
Composite
Wood
Products
NESHAP.
3
Table
1.
Number
of
impacted
facilities.

Scenario
No.
of
major
source
facilities
No.
of
major
source
facilities
with
no
equipment
subject
to
control
requirements
No.
of
major
source
facilities
with
all
the
controls
necessary
to
meet
MACTa
No.
of
facilities
impacted
by
control
requirements
No
low­
risk
subcategory
223
11
46
166
Facilities
currently
eligible
for
the
lowrisk
subcategory
8
­­
4
4
Facilities
that
may
later
be
eligible
for
the
low­
risk
subcategory
following
submission
of
a
low­
risk
demonstration
147
3
36
108
aIncludes
some
facilities
that
have
equipment
subject
to
work
practices
only.
4
Table
2.
Nationwide
cost
impacts.

Scenario
No.
of
major
source
facilities
Nationwide
costs
Nationwide
cost
following
removal
of
the
facilities
in
the
low­
risk
subcategory
Total
capital
cost,

$
MM
Total
annualized
cost,
$
MM
Total
capital
cost,

$
MM
Total
annualized
cost,
$
MM
No
low­
risk
subcategory
223
$
479
$
142
Facilities
currently
eligible
for
the
low­
risk
subcategory
8
$
8.5
$
2.4
$
471
$
140
Facilities
that
may
later
be
eligible
for
the
low­
risk
subcategory
following
submission
of
a
low­
risk
demonstration
147
$
239
$
68
$
240
$
74
5
Table
3.
Nationwide
Air
Impacts
at
PCWP
Facilities.

Scenario
No.
of
major
source
facilities
HAP
emission
reduction,

tons/
yr
THC
emission
reduction,

tons/
yr
NOx
emissions
increase,

tons/
yr
CO
emission
reduction,

tons/
yr
PM­
10
emission
reduction,

tons/
yr
Impacts
associated
with
each
scenario:

No
low­
risk
subcategory
223
10,737
27,178
2,375
10,772
12,684
Facilities
currently
eligible
for
the
low­
risk
subcategory
8
77
458
22
275
187
Facilities
that
may
later
be
eligible
for
the
low­
risk
subcategory
following
submission
of
a
low­
risk
demonstration
147
4,186
13,283
1,159
2,377
6,818
Nationwide
impacts
following
removal
of
the
facilities
in
the
low­
risk
subcategory:

Facilities
currently
eligible
for
the
low­
risk
subcategory
162
impacted
10,660
26,720
2,353
10,497
12,497
Facilities
that
may
later
be
eligible
for
the
low­
risk
subcategory
following
submission
of
a
low­
risk
demonstration
58
impacted
6,551
13,437
1,216
8,395
5,866
6
Table
4.
Nationwide
Secondary
Air
Impacts
Based
on
Worst­
Case
Assumption
of
Electricity
Generation
at
Coal­
fired
Utilities.
Scenario
No.
of
major
source
facilities
Secondary
CO
emissions,
tons/
yr
Secondary
NOx
emissions,
tons/
yr
Secondary
SO2
emissions,
tons/
yr
Secondary
PM­
10
emissions,
tons/
yr
Impacts
associated
with
each
scenario:

No
low­
risk
subcategory
223
73
2,229
4,457
111
Facilities
currently
eligible
for
the
lowrisk
subcategory
8
1
20
40
1
Facilities
that
may
later
be
eligible
for
the
low­
risk
subcategory
following
submission
of
a
low­
risk
demonstration
147
34
1,054
2,108
53
Nationwide
impacts
following
removal
of
the
facilities
in
the
low­
risk
subcategory:

Facilities
currently
eligible
for
the
lowrisk
subcategory
162
impacted
72
2,209
4,417
110
Facilities
that
may
later
be
eligible
for
the
low­
risk
subcategory
following
submission
of
a
low­
risk
demonstration
58
impacted
39
1,175
2,349
58
7
Table
5.
Nationwide
Wastewater,
Solid
Waste,
and
Energy
Impacts.

Scenario
No.
of
major
source
facilities
Wastewater
impacts,

thousand
gal/
yra
Solid
waste
impacts,

ton/
yrb
Electricity
use,

GWh/
yrc
Fuel
use,
Billion
Btu/
yr
Impacts
associated
with
each
scenario:

No
low­
risk
subcategory
223
27,295
4,985
718
1,638
Facilities
currently
eligible
for
the
lowrisk
subcategory
8
42
37
6
12
Facilities
that
may
later
be
eligible
for
the
low­
risk
subcategory
following
submission
of
a
low­
risk
demonstration
147
3,455
1,949
340
744
Nationwide
impacts
following
removal
of
the
facilities
in
the
low­
risk
subcategory:

Facilities
currently
eligible
for
the
lowrisk
subcategory
162
impacted
27,253
4,948
711
1,625
Facilities
that
may
later
be
eligible
for
the
low­
risk
subcategory
following
submission
of
a
low­
risk
demonstration
58
impacted
23,840
3,036
378
894
aIncludes
RTO
washwater
and
WESP
blowdown.

bIncludes
RTO
media
disposal
and
WESP
wastewater
solids.

cIncludes
electricity
use
for
RTO
and
WESP
operation.

Note:
Values
in
table
may
not
sum
exactly
due
to
rounding.
ATTACHMENT
1
List
of
147
Low­
risk
Facilities
Facilities
with
cancer
risk
level
of
one
in
a
million
and
TOSHI
limits
of
less
than
1.0
for
respiratory
and
CNS
effects
Plant
#
Concentration
People
Exposure
Lifetime
Cancer
Incidence
HI
for
respiratory
effects*

442B
1.48E­
04
103
1.53E­
02
1.53E­
02
1.48E­
04
60A
3.16E­
03
42
1.33E­
01
1.33E­
01
3.16E­
03
142B
4.19E­
03
4
1.68E­
02
1.68E­
02
4.19E­
03
13
4.22E­
03
3
1.27E­
02
1.27E­
02
4.22E­
03
82
4.50E­
03
6
2.70E­
02
2.70E­
02
4.50E­
03
174
4.89E­
03
24
1.17E­
01
1.17E­
01
4.89E­
03
151
5.02E­
03
48
2.41E­
01
2.41E­
01
5.02E­
03
117
5.96E­
03
1
5.96E­
03
5.96E­
03
5.96E­
03
464
6.39E­
03
4
2.56E­
02
2.56E­
02
6.39E­
03
185
7.55E­
03
3
2.27E­
02
2.27E­
02
7.55E­
03
167
7.73E­
03
92
7.11E­
01
7.11E­
01
7.73E­
03
30
7.82E­
03
72
5.63E­
01
5.63E­
01
7.82E­
03
77
8.16E­
03
140
1.14E+
00
1.14E+
00
8.16E­
03
187
8.97E­
03
35
3.14E­
01
3.14E­
01
8.97E­
03
98A
8.97E­
03
31
2.78E­
01
2.78E­
01
8.97E­
03
135
9.04E­
03
12
1.08E­
01
1.08E­
01
9.04E­
03
72
9.17E­
03
5
4.58E­
02
4.58E­
02
9.17E­
03
92
9.70E­
03
2
1.94E­
02
1.94E­
02
9.70E­
03
73
9.89E­
03
5
4.94E­
02
4.94E­
02
9.89E­
03
89
9.98E­
03
32
3.20E­
01
3.20E­
01
9.98E­
03
79
1.05E­
02
21
2.21E­
01
2.21E­
01
1.05E­
02
442A
1.14E­
02
3
3.43E­
02
3.43E­
02
1.14E­
02
186
1.27E­
02
13
1.65E­
01
1.65E­
01
1.27E­
02
47
1.39E­
02
42
5.82E­
01
5.82E­
01
1.39E­
02
192
1.44E­
02
16
2.31E­
01
2.31E­
01
1.44E­
02
74
1.49E­
02
12
1.79E­
01
1.79E­
01
1.49E­
02
91
1.63E­
02
1
1.63E­
02
1.63E­
02
1.63E­
02
45
2.00E­
02
6
1.20E­
01
1.20E­
01
2.00E­
02
81
2.08E­
02
22
4.57E­
01
4.57E­
01
2.08E­
02
99
2.40E­
02
42
1.01E+
00
1.01E+
00
2.40E­
02
431
2.49E­
02
3
7.47E­
02
7.47E­
02
2.49E­
02
166
2.60E­
02
4
1.04E­
01
1.04E­
01
2.60E­
02
161
2.62E­
02
3
7.85E­
02
7.85E­
02
2.62E­
02
Plant
#
Concentration
People
Exposure
Lifetime
Cancer
Incidence
HI
for
respiratory
effects*

141
2.75E­
02
24
6.60E­
01
6.60E­
01
2.75E­
02
183
2.81E­
02
10
2.81E­
01
2.81E­
01
2.81E­
02
229
2.95E­
02
27
7.98E­
01
7.98E­
01
2.95E­
02
41
3.07E­
02
23
7.05E­
01
7.05E­
01
3.07E­
02
33
3.10E­
02
24
7.44E­
01
7.44E­
01
3.10E­
02
118
3.31E­
02
77
2.55E+
00
2.55E+
00
3.31E­
02
162
3.43E­
02
20
6.86E­
01
6.86E­
01
3.43E­
02
1
3.74E­
02
18
6.72E­
01
6.72E­
01
3.74E­
02
443A
4.39E­
02
143
6.27E+
00
6.27E+
00
4.39E­
02
220
4.46E­
02
344
1.53E+
01
1.53E+
01
4.46E­
02
230
4.53E­
02
5
2.27E­
01
2.27E­
01
4.53E­
02
209
4.87E­
02
20
9.73E­
01
9.73E­
01
4.87E­
02
25
5.02E­
02
98
4.92E+
00
4.92E+
00
5.02E­
02
238
5.05E­
02
8
4.04E­
01
4.04E­
01
5.05E­
02
466
5.07E­
02
179
9.07E+
00
9.07E+
00
5.07E­
02
80
5.56E­
02
6
3.34E­
01
3.34E­
01
5.56E­
02
112
5.68E­
02
143
8.12E+
00
8.12E+
00
5.68E­
02
113
5.94E­
02
83
4.93E+
00
4.93E+
00
5.94E­
02
58A
5.97E­
02
211
1.26E+
01
1.26E+
01
5.97E­
02
208
6.00E­
02
223
1.34E+
01
1.34E+
01
6.00E­
02
142A
6.12E­
02
1
6.12E­
02
6.12E­
02
6.12E­
02
156
6.46E­
02
3
1.94E­
01
1.94E­
01
6.46E­
02
150
6.69E­
02
1
6.69E­
02
6.69E­
02
6.69E­
02
103
6.75E­
02
9
6.07E­
01
6.07E­
01
6.75E­
02
159
6.95E­
02
110
7.65E+
00
7.65E+
00
6.95E­
02
105
7.02E­
02
7
4.91E­
01
4.91E­
01
7.02E­
02
237
7.12E­
02
15
1.07E+
00
1.07E+
00
7.12E­
02
157
7.13E­
02
39
2.78E+
00
2.78E+
00
7.13E­
02
48
7.27E­
02
51
3.71E+
00
3.71E+
00
7.27E­
02
115
7.88E­
02
2
1.58E­
01
1.58E­
01
7.88E­
02
197
7.89E­
02
9
7.10E­
01
7.10E­
01
7.89E­
02
175
8.12E­
02
7
5.68E­
01
5.68E­
01
8.12E­
02
212
8.18E­
02
3
2.46E­
01
2.46E­
01
8.18E­
02
64
8.49E­
02
13
1.10E+
00
1.10E+
00
8.49E­
02
Plant
#
Concentration
People
Exposure
Lifetime
Cancer
Incidence
HI
for
respiratory
effects*

97
8.62E­
02
8
6.90E­
01
6.90E­
01
8.62E­
02
15
8.69E­
02
22
1.91E+
00
1.91E+
00
8.69E­
02
102
8.87E­
02
7
6.21E­
01
6.21E­
01
8.87E­
02
207
8.98E­
02
14
1.26E+
00
1.26E+
00
8.98E­
02
65
9.00E­
02
24
2.16E+
00
2.16E+
00
9.00E­
02
2
9.18E­
02
9
8.26E­
01
8.26E­
01
9.18E­
02
19
9.59E­
02
3
2.88E­
01
2.88E­
01
9.59E­
02
37
1.13E­
01
19
2.14E+
00
2.14E+
00
1.13E­
01
194
1.13E­
01
4
4.52E­
01
4.52E­
01
1.13E­
01
18
1.14E­
01
10
1.14E+
00
1.14E+
00
1.14E­
01
101
1.14E­
01
31
3.54E+
00
3.54E+
00
1.14E­
01
57
1.17E­
01
33
3.87E+
00
3.87E+
00
1.17E­
01
76
1.17E­
01
7
8.20E­
01
8.20E­
01
1.17E­
01
178
1.18E­
01
11
1.30E+
00
1.30E+
00
1.18E­
01
180
1.18E­
01
5
5.91E­
01
5.91E­
01
1.18E­
01
190
1.21E­
01
4
4.83E­
01
4.83E­
01
1.21E­
01
144
1.27E­
01
83
1.05E+
01
1.05E+
01
1.27E­
01
146
1.29E­
01
52
6.71E+
00
6.71E+
00
1.29E­
01
176
1.30E­
01
18
2.33E+
00
2.33E+
00
1.30E­
01
107
1.31E­
01
4
5.25E­
01
5.25E­
01
1.31E­
01
235
1.34E­
01
15
2.00E+
00
2.00E+
00
1.34E­
01
24
1.38E­
01
131
1.81E+
01
1.81E+
01
1.38E­
01
50
1.46E­
01
7
1.02E+
00
1.02E+
00
1.46E­
01
199
1.50E­
01
2
3.00E­
01
3.00E­
01
1.50E­
01
469
1.52E­
01
97
1.48E+
01
1.48E+
01
1.52E­
01
120
1.54E­
01
186
2.86E+
01
2.86E+
01
1.54E­
01
22
1.56E­
01
32
5.00E+
00
5.00E+
00
1.56E­
01
139
1.58E­
01
21
3.32E+
00
3.32E+
00
1.58E­
01
39
1.59E­
01
4
6.34E­
01
6.34E­
01
1.59E­
01
17
1.66E­
01
107
1.78E+
01
1.78E+
01
1.66E­
01
110
1.66E­
01
25
4.15E+
00
4.15E+
00
1.66E­
01
465
1.67E­
01
103
1.72E+
01
1.72E+
01
1.67E­
01
164
1.68E­
01
2
3.36E­
01
3.36E­
01
1.68E­
01
200
1.70E­
01
7
1.19E+
00
1.19E+
00
1.70E­
01
Plant
#
Concentration
People
Exposure
Lifetime
Cancer
Incidence
HI
for
respiratory
effects*

49
1.98E­
01
2
3.97E­
01
3.97E­
01
1.98E­
01
106
2.01E­
01
71
1.43E+
01
1.43E+
01
2.01E­
01
134
2.18E­
01
10
2.18E+
00
2.18E+
00
2.18E­
01
140
2.24E­
01
60
1.34E+
01
1.34E+
01
2.24E­
01
52
2.26E­
01
24
5.42E+
00
5.42E+
00
2.26E­
01
40
2.27E­
01
37
8.40E+
00
8.40E+
00
2.27E­
01
203
2.35E­
01
2
4.70E­
01
4.70E­
01
2.35E­
01
131
2.37E­
01
16
3.79E+
00
3.79E+
00
2.37E­
01
51
2.40E­
01
3
7.19E­
01
7.19E­
01
2.40E­
01
133
2.50E­
01
6
1.50E+
00
1.50E+
00
2.50E­
01
93
2.57E­
01
1
2.57E­
01
2.57E­
01
2.57E­
01
143
2.61E­
01
39
1.02E+
01
1.02E+
01
2.61E­
01
21
2.67E­
01
56
1.49E+
01
1.49E+
01
2.67E­
01
145
2.68E­
01
11
2.95E+
00
2.95E+
00
2.68E­
01
198
3.03E­
01
6
1.82E+
00
1.82E+
00
3.03E­
01
109
3.19E­
01
13
4.15E+
00
4.15E+
00
3.19E­
01
160
3.19E­
01
7
2.23E+
00
2.23E+
00
3.19E­
01
104
3.31E­
01
9
2.98E+
00
2.98E+
00
3.31E­
01
46
3.38E­
01
15
5.07E+
00
5.07E+
00
3.38E­
01
222
3.50E­
01
24
8.41E+
00
8.41E+
00
3.50E­
01
86
3.60E­
01
15
5.40E+
00
5.40E+
00
3.60E­
01
137
3.81E­
01
1
3.81E­
01
3.81E­
01
3.81E­
01
189
3.81E­
01
10
3.81E+
00
3.81E+
00
3.81E­
01
111
4.02E­
01
37
1.49E+
01
1.49E+
01
4.02E­
01
53
4.28E­
01
2
8.55E­
01
8.55E­
01
4.28E­
01
210
4.29E­
01
32
1.37E+
01
1.37E+
01
4.29E­
01
165
4.31E­
01
46
1.98E+
01
1.98E+
01
4.31E­
01
201
4.40E­
01
258
1.13E+
02
1.13E+
02
4.40E­
01
173
4.46E­
01
35
1.56E+
01
1.56E+
01
4.46E­
01
184
4.54E­
01
3
1.36E+
00
1.36E+
00
4.54E­
01
138
4.87E­
01
71
3.46E+
01
3.46E+
01
4.87E­
01
100
5.28E­
01
17
8.98E+
00
8.98E+
00
5.28E­
01
196
5.44E­
01
11
5.98E+
00
5.98E+
00
5.44E­
01
154
5.55E­
01
3
1.66E+
00
1.66E+
00
5.55E­
01
Plant
#
Concentration
People
Exposure
Lifetime
Cancer
Incidence
HI
for
respiratory
effects*

78
5.56E­
01
85
4.72E+
01
4.72E+
01
5.56E­
01
121
5.62E­
01
12
6.74E+
00
6.74E+
00
5.62E­
01
206
5.72E­
01
17
9.72E+
00
9.72E+
00
5.72E­
01
38
5.80E­
01
1
5.80E­
01
5.80E­
01
5.80E­
01
436
6.00E­
01
5
3.00E+
00
3.00E+
00
6.00E­
01
108
6.26E­
01
3
1.88E+
00
1.88E+
00
6.26E­
01
23B
6.37E­
01
52
3.31E+
01
3.31E+
01
6.37E­
01
152B
6.52E­
01
61
3.97E+
01
3.97E+
01
6.52E­
01
224
6.80E­
01
44
2.99E+
01
2.99E+
01
6.80E­
01
95
7.44E­
01
64
4.76E+
01
4.76E+
01
7.44E­
01
188
7.74E­
01
10
7.74E+
00
7.74E+
00
7.74E­
01
128
8.69E­
01
227
1.97E+
02
1.97E+
02
8.69E­
01
*
All
facilities
with
a
respiratory
TOSHI
of
less
than
1
also
have
TOSHI
of
less
than
1
for
CNS
and
other
effects
(
i.
e.,
blood,
kidney,
developmental).
